SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-16-678209
Filing Date
2016-08-10
Accepted
2016-08-10 17:14:00
Documents
64
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A d225552d10qa.htm 10-Q/A 17428
2 EX-31 d225552dex31.htm EX-31 2714
  Complete submission text file 0001193125-16-678209.txt   3200651

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT mnkd-20160630.xml EX-101.INS 513900
4 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20160630.xsd EX-101.SCH 49124
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnkd-20160630_cal.xml EX-101.CAL 63720
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnkd-20160630_def.xml EX-101.DEF 312867
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20160630_lab.xml EX-101.LAB 377564
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20160630_pre.xml EX-101.PRE 363098
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-50865 | Film No.: 161822237
SIC: 2834 Pharmaceutical Preparations